Cargando…

New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA

Detalles Bibliográficos
Autores principales:	Di Giorgio, Audrey, Duca, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553036/ https://www.ncbi.nlm.nih.gov/pubmed/33140031 http://dx.doi.org/10.1021/acscentsci.0c01187

Ejemplares similares

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2
por: Di Giorgio, Salvatore, et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

An ultrafast SARS-CoV-2 virus enrichment and extraction method compatible with multiple modalities for RNA detection
por: Dignan, Leah M., et al.
Publicado: (2021)

SARS-CoV-2 Nsp1 mediated mRNA degradation requires mRNA interaction with the ribosome
por: Shehata, Soraya I., et al.
Publicado: (2023)

Ozone Disinfection for Elimination of Bacteria and Degradation of SARS-CoV2 RNA for Medical Environments
por: Westover, Craig, et al.
Publicado: (2022)

The SARS-CoV-2 RNA interactome
por: Lee, Sungyul, et al.
Publicado: (2021)

Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
por: Parashar, Nidarshana Chaturvedi, et al.
Publicado: (2020)

Commentary on “Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2”
por: Martignano, F., et al.
Publicado: (2022)

Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
por: Farr, Ryan J., et al.
Publicado: (2021)

From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines
por: Lopez-Cantu, Diana O., et al.
Publicado: (2022)

Dynamic properties of SARS-CoV and SARS-CoV-2 RNA-dependent RNA polymerases studied by molecular dynamics simulations
por: Itoh, Satoru G., et al.
Publicado: (2021)

Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate
por: Iserman, Christiane, et al.
Publicado: (2020)

SARS-CoV-2 RNA Detection with Duplex-Specific Nuclease Signal Amplification
por: Liu, Meiqing, et al.
Publicado: (2021)

Inhibition of SARS-CoV replication by siRNA
por: Wu, Chang-Jer, et al.
Publicado: (2005)

ceRNA analysis of SARS-CoV-2
por: Arancio, Walter
Publicado: (2020)

The mechanism of RNA capping by SARS-CoV-2
por: Park, Gina J., et al.
Publicado: (2022)

The mechanism of RNA capping by SARS-CoV-2
por: Park, Gina J., et al.
Publicado: (2022)

Engineered RNA biosensors enable ultrasensitive SARS-CoV-2 detection in a simple color and luminescence assay
por: Chakravarthy, Anirudh, et al.
Publicado: (2021)

SARS-CoV-2 RNA Persistence in Naso-Pharyngeal Swabs
por: Danzetta, Maria Luisa, et al.
Publicado: (2020)

The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2
por: Ziv, Omer, et al.
Publicado: (2020)

Absence of SARS‐CoV‐2 RNA and anti‐SARS‐CoV‐2 antibodies in stray cats
por: Stranieri, Angelica, et al.
Publicado: (2021)

Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5’ untranslated region
por: Tang, Zhichao, et al.
Publicado: (2023)

Comparison of the clinical sensitivity and specificity of two commercial RNA SARS-CoV-2 assays
por: Litchfield, Mark, et al.
Publicado: (2022)

Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders
por: Haniff, Hafeez S., et al.
Publicado: (2020)

SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
por: Gupta, Ishita, et al.
Publicado: (2020)

An efficient metatranscriptomic approach for capturing RNA virome and its application to SARS-CoV-2
por: Meng, Yao, et al.
Publicado: (2021)

Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests
por: Valley-Omar, Ziyaad, et al.
Publicado: (2022)

An in silico map of the SARS-CoV-2 RNA Structurome
por: Andrews, Ryan J., et al.
Publicado: (2020)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva
por: Ott, Isabel M., et al.
Publicado: (2021)

Enisamium Inhibits SARS-CoV-2 RNA Synthesis
por: Elli, Stefano, et al.
Publicado: (2021)

SARS-CoV-2 RNA loads in Vietnamese children
por: Thanh, Ton That, et al.
Publicado: (2022)

SARS-CoV-2 RNA and antibodies in tear fluid
por: Muyldermans, Astrid, et al.
Publicado: (2021)

A map of the SARS-CoV-2 RNA structurome
por: Andrews, Ryan J, et al.
Publicado: (2021)

Sensitive methods for detection of SARS-CoV-2 RNA
por: Chen, Xi, et al.
Publicado: (2022)

SARS-CoV-2 RNA levels in Scotland’s wastewater
por: Scorza, Livia C. T., et al.
Publicado: (2022)

Rapid Degradation of SARS-CoV-2 Spike S Protein by A Specific Serine Protease
por: Liu, Jiankai, et al.
Publicado: (2022)

Contribution of SARS-CoV-2 RNA shedding routes to RNA loads in wastewater
por: Crank, K., et al.
Publicado: (2022)

A small interfering RNA (siRNA) database for SARS-CoV-2
por: Medeiros, Inácio Gomes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5gn6edjik0o582nbfvehilpdon